Detalhe da pesquisa
1.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Lancet Oncol
; 24(7): 772-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276871
2.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
N Engl J Med
; 381(17): 1632-1643, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566309
3.
Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases.
Clin Exp Dermatol
; 47(10): 1857-1858, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633107
4.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 22(5): 690-701, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798493
5.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Lancet Oncol
; 22(10): 1468-1482, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592180
6.
Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog-mediated epithelial-mesenchymal transition.
Cancer Sci
; 112(10): 4176-4186, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327778
7.
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
Oncologist
; 26(4): e669-e678, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210382
8.
Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer.
Int J Cancer
; 147(4): 1078-1085, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31840815
9.
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
J Hepatol
; 73(5): 1109-1117, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446715
10.
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Future Oncol
; 16(30): 2385-2399, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677452
11.
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Lancet Oncol
; 20(5): 663-673, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922733
12.
Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study.
Future Oncol
; 15(15): 1745-1758, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31038364
13.
Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis.
HPB (Oxford)
; 21(7): 773-783, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733049
14.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611518
15.
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.
Br J Cancer
; 119(7): 815-822, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206366
16.
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
Br J Cancer
; 119(1): 27-35, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925934
17.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420616
18.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Lancet
; 389(10073): 1011-1024, 2017 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129987
19.
Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More.
Neuroendocrinology
; 106(3): 242-251, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28641291
20.
Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab.
J Med Genet
; 54(8): 567-571, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283541